The Central Bureau of Investigation (CBI) said on Thursday that it has arrested seven accused persons, including then senior officials of Eastern Coalfields Ltd (ECL), in connection with fraudulent misappropriation of coal from the coal reserve of leasehold areas under the dominion of ECL.
The Central Bureau of Investigation (CBI) said on Thursday that it has arrested seven accused persons, including then senior officials of Eastern Coalfields Ltd (ECL), in connection with fraudulent misappropriation of coal from the coal reserve .
The CBI has arrested seven accused, including two then GMs, of Eastern Coalfields Ltd. in an on-going investigation of a case related to misappropriation of coal from the coal reserve of leasehold areas under the dominion of ECL.
Nanotechnology Now
Our NanoNews Digest Sponsors
Home > Press > Nanoparticle drug delivery technique shows promise for treating pancreatic cancer: Method may also work for breast, prostate, ovarian cancer
Study researchers Drs. Snigdha Banerjee, Suman Kambhampati, Sushanta Banerjee, and a colleague examine a pancreatic cancer image.
CREDIT
Jeff Gates
Abstract:
Researchers with the Kansas City Veterans Affairs Medical Center and North Dakota State University have designed a new way to deliver pancreatic cancer drugs that could make fighting the disease much easier. Encapsulating cancer drugs in nanoparticles shows potential to target tumors more effectively and avoid danger to other parts of the body.
E-Mail
IMAGE: Study researchers Drs. Snigdha Banerjee, Suman Kambhampati, Sushanta Banerjee, and a colleague examine a pancreatic cancer image. view more
Credit: Jeff Gates
Researchers with the Kansas City Veterans Affairs Medical Center and North Dakota State University have designed a new way to deliver pancreatic cancer drugs that could make fighting the disease much easier. Encapsulating cancer drugs in nanoparticles shows potential to target tumors more effectively and avoid danger to other parts of the body.
The study results appeared in the Jan. 4, 2021, issue of the journal
Molecular Pharmaceutics.
Study author Dr. Sushanta Banerjee, a researcher with the Kansas City VA and University of Kansas medical centers, explains that this technology has the potential to drastically improve Veterans cancer care. Veteran health care will benefit immensely from such therapeutic models, as they are effective in delivering the drug to the tumor site without any toxic